Physician

Dina Y. Gewaily, MD

According to 2025 Medicare claims, Dina Gewaily, MD (NPI: 1104054048) practices ophthalmology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is LANCASTER RETINA SPECIALISTS PC (NPI: 1558785725; TIN: 464711594) and primary practice location at 17601-2644. Gewaily is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Gewaily's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 848 traditional Medicare patients, billed 29,442 HCPCS/CPT codes, and received $1,952,471 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 515 prescription claims across 129 beneficiaries totaling $17,872 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 10 records totaling $333. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $164,435 to $1,952,471. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,716 to $17,872. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$976K$2.0M2015 Medicare payment: $164,435 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $545,211 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $509,714 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $353,709 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $583,297 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $696,619 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,720,653 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,736,635 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,870,612 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,952,471 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015223909$164,435
20165873,540$545,211
20176093,479$509,714
20184822,841$353,709
20195165,023$583,297
20205415,662$696,619
202196210,251$1,720,653
202281110,531$1,736,635
202386322,912$1,870,612
202484829,442$1,952,471

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $3,716 (USD; Tot_Drug_Cst)2016 Drug cost: $9,642 (USD; Tot_Drug_Cst)2017 Drug cost: $10,903 (USD; Tot_Drug_Cst)2018 Drug cost: $8,998 (USD; Tot_Drug_Cst)2019 Drug cost: $21,126 (USD; Tot_Drug_Cst)2020 Drug cost: $24,603 (USD; Tot_Drug_Cst)2021 Drug cost: $32,001 (USD; Tot_Drug_Cst)2022 Drug cost: $29,060 (USD; Tot_Drug_Cst)2023 Drug cost: $22,162 (USD; Tot_Drug_Cst)2024 Drug cost: $17,872 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201538103$3,716
201645171$9,642
201754197$10,903
201861195$8,998
201994352$21,126
2020109362$24,603
2021149441$32,001
2022144431$29,060
2023141475$22,162
2024129515$17,872

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3241,569$82
J7999Compounded drug, not otherwise classified159580$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6451,030$59
92134Imaging of retina6652,022$28
92250Photography of the retina684789$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate621,876$6,804
Prednisolone AcetatePrednisolone Acetate1564,618$4,774
Brimonidine TartrateBrimonidine Tartrate552,477$717
OfloxacinOfloxacin611,532$655
Ketorolac TromethamineKetorolac Tromethamine33853$414

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$333SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dina Y. Gewaily, MD?

Tedicare shows public-source Medicare data for Dina Y. Gewaily, MD (NPI 1104054048), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dina Y. Gewaily, MD have ACO affiliation data?

Dina Y. Gewaily, MD is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Dina Y. Gewaily, MD?

Dina Y. Gewaily, MD is linked to LANCASTER RETINA SPECIALISTS PC (billing NPI 1558785725) in the available physician profile data.

Does Dina Y. Gewaily, MD have Open Payments data?

Dina Y. Gewaily, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.